| Factors | No. of patients | 3 DFS % | 5 years DFS | P value (univariate) | P value (multivariate) |
| Age (years) <60 ≥60 |
32 56 |
84.5 41.1 |
65.7 32.4 | 0.001 | 0.005 |
| Pretreatment Hemoglobin <12 g/dl ≥12 g/dl |
29 17 |
43.4 65.7 |
32.5 52.5 | 0.117 |
|
| Pathology Papillary Serous Clear Cell Undifferentiated Carcinosarcoma |
29 12 8 39 |
44.2 72.9 68.6 60.6 |
44.2 72.9 51.4 26.9 | 0.666 |
|
| Lymph nodes Nx N0 N+ |
64 17 7 |
52.1 94.1 41.7 |
41.4 70.6 0 | 0.089 |
|
| FIGO stage Early (I,II) Late (III,IV) |
68 20 |
62.7 0 |
52.0 0 | <0.001 | 0.026 |
| ERBT No Yes |
8 80 |
38.1 59.0 |
38.1 44.9 | 0.694 |
|
| Brachytherapy Yes No |
49 39 |
70.9 40.5 |
57.3 27.0 | 0.004 | 0.011 |
| Chemotherapy Yes No |
8 78 |
72.9 54.3 |
72.9 41.2 |
0.273 |
|
| Factors | No. of patients | 3 DFS % | 5 years DFS | P value (univariate) | P value (multivariate) |
| Duration from surgery to ERBT ≤2 months >2 months |
48 32 |
59.2 59.1 |
50.1 29.6 | 0.866 |
|